Classification criteria for most of the disorders belonging to the spondylarthropathy group
already exist. However, the spectrum of spondylarthropathy is wider than the sum of these …

Objective A 2‐year randomized controlled trial was performed to test the hypothesis that
long‐term, continuous treatment with nonsteroidal antiinflammatory drugs (NSAIDs), in …

Objective. To assess the efficacy and tolerability of sulfasalazine (SSZ) in the treatment of
spondyl‐arthropathy. Methods. We conducted a 6‐month randomized, placebo‐controlled, …

Objective Ankylosing spondylitis (AS) is diagnosed late, because radiographs of the sacroiliac
joints often do not show definite sacroiliitis at the time of disease onset. The aim of this …

Background Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX),
which leads to suppression of COX-1-mediated production of gastrointestinal-protective …

Objective To assess prospectively the rates and to explore predictors of spinal radiographic
progression over 2 years in a cohort of patients with early axial spondylarthritis (SpA). …

Eighty-eight patients with possible ankylosing spondylitis (AS) were selected for this followup
study. They showed normal or at most suspicious radiographic findings of the sacroiliac …

Objective To assess the progression of radiographic sacroiliitis in a cohort of patients with
early axial spondyloarthritis over a period of 2 years and to explore predictors of progression. …

Objective To investigate the influence of non-steroidal anti-inflammatory drugs (NSAIDs)
intake on radiographic spinal progression over 2 years in patients with ankylosing spondylitis (…

Objective To evaluate the short‐term efficacy of celecoxib, a cyclooxygenase 2–specific
inhibitor, in the treatment of ankylosing spondylitis (AS). Methods The study was a 6‐week …